Atazanavir sulfate
CAS No. 229975-97-7
Atazanavir sulfate ( BMS 232632 sulfate;BMS-232632 sulfate;BMS232632 sulfate )
Catalog No. M13641 CAS No. 229975-97-7
A highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 35 | In Stock |
|
10MG | 57 | In Stock |
|
25MG | 88 | In Stock |
|
50MG | 113 | In Stock |
|
100MG | 194 | In Stock |
|
200MG | 291 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAtazanavir sulfate
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture.
-
DescriptionA highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture; shows synergistic antiviral effects in HIV-infected PBMCs; used to treat and prevent HIV/AIDS.HIV Infection Approved
-
SynonymsBMS 232632 sulfate;BMS-232632 sulfate;BMS232632 sulfate
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIVprotease
-
Research AreaInfection
-
IndicationHIV Infection
Chemical Information
-
CAS Number229975-97-7
-
Formula Weight802.93
-
Molecular FormulaC38H54N6O11S
-
Purity>98% (HPLC)
-
SolubilityDMSO; H2O: < 0.1 mg/mL
-
SMILESCC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O
-
Chemical Name2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-, sulfate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Robinson BS, et al. Antimicrob Agents Chemother. 2000 Aug;44(8):2093-9.
2. Gong YF, et al. Antimicrob Agents Chemother. 2000 Sep;44(9):2319-26.
3. Drusano GL, et al. J Infect Dis. 2001 Apr 1;183(7):1126-9.
2. Gong YF, et al. Antimicrob Agents Chemother. 2000 Sep;44(9):2319-26.
3. Drusano GL, et al. J Infect Dis. 2001 Apr 1;183(7):1126-9.
molnova catalog
related products
-
YIR-821
YIR-821 is a small-molecule CD4 mimic that acts as a highly potent HIV entry inhibitor with IC50 of 2.8 uM against YTA48P virus with no significant cytotoxicity (CC50>200 uM).
-
1E7-03
1E7-03 is a small molecule targeting the RVxF interacting site on PP1, inhibits HIV-1, Ebolavirus (EBOV), and Venezuelan equine encephalitis virus (VEEV, EC50=0.6 uM).
-
Zidovudine
A nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.